COST EFFECTIVENESS OF ORAL PERICALCITOL IN PATIENTS WITH STAGE III-IV CHRONIC KIDNEY DISEASE AND SECONDARY HYPERPARATHYREOSIS
| Autor: | A. V. Rudakova |
|---|---|
| Jazyk: | ruština |
| Rok vydání: | 2015 |
| Předmět: | |
| Zdroj: | Фармакоэкономика, Vol 5, Iss 2, Pp 13-16 (2015) |
| Druh dokumentu: | article |
| ISSN: | 2070-4909 2070-4933 |
| Popis: | results of clinical trials demonstrate that selective vitamin D receptor agonist paricalcitoldecreases proteinuria in patients with chronic kidney disease (CKD) and hyperparathyreosis. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|